ArticleTuberculosis and respiratory diseases2023

An Open-Label, Multicentre, Observational, Post-Marketing Study to Monitor the Safety and Effectiveness of Umeclidinium/Vilanterol in Korean Patients.

Eun-Yeong Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.